165 related articles for article (PubMed ID: 19840471)
1. [Effect of mesenchymal stem cells on expression of CD69 in cord blood CIK/NK cells and quantity ratio of T regulatory cells in CIK/NK cell culture].
Li Y; Wei J; Wu YF; Wang XP; Huang K; Lin YC; Huang SL; Fang JP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1301-6. PubMed ID: 19840471
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow mesenchymal stem cells suppressing activation of allogeneic cytokine-induced killer/natural killer cells either by direct or indirect interaction.
Li Y; Qu YH; Wu YF; Liu L; Lin XH; Huang K; Wei J
Cell Biol Int; 2015 Apr; 39(4):435-45. PubMed ID: 25492047
[TBL] [Abstract][Full Text] [Related]
3. [Thymoglobulin efficiently expands cytokine-induced killer cells in a clinical-grade culture protocol].
Chen W; Lin D; Jiang Z; Yang Z; Song S; Zhou J; Zhou L; Sun Y; Yu H; Ma D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jul; 30(7):681-5, 690. PubMed ID: 25001928
[TBL] [Abstract][Full Text] [Related]
4. [Distribution and interaction of bone marrow mesenchymal stem cells and cord blood CIK/NK cells infused via different ways at different time periods in NOD/SCID mice].
Li Y; Wang XP; Guo HX; Huang K; Wei J; Zhou DH; Huang WG; Wu YF; Huang SL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):140-5. PubMed ID: 20137135
[TBL] [Abstract][Full Text] [Related]
5. Expansion of natural killer cell receptor (CD94/NKG2A)-expressing cytolytic CD8 T cells and CD4+CD25+ regulatory T cells from the same cord blood unit.
Tanaka J; Sugita J; Kato N; Toubai T; Ibata M; Shono Y; Ota S; Kondo T; Kobayashi T; Kobayashi M; Asaka M; Imamura M
Exp Hematol; 2007 Oct; 35(10):1562-6. PubMed ID: 17681668
[TBL] [Abstract][Full Text] [Related]
6. Non-traditional CD4+CD25-CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation.
Zhao XS; Wang XH; Zhao XY; Chang YJ; Xu LP; Zhang XH; Huang XJ
J Transl Med; 2014 Jul; 12():187. PubMed ID: 24984576
[TBL] [Abstract][Full Text] [Related]
7. Gemcitabine treatment enhanced the anti-tumor effect of cytokine induced killer cells by depletion of CD4
Zhao P; Zhu D; Zhang Z; Han B; Gao D; Wei X; Xie X; Li C; Sun W; Wang Q; Guo Q
Immunol Lett; 2017 Jan; 181():36-44. PubMed ID: 27867030
[TBL] [Abstract][Full Text] [Related]
8. A study on mutual interaction between cytokine induced killer cells and umbilical cord-derived mesenchymal cells: Implication for their in-vivo use.
Chieregato K; Albiero E; Castegnaro S; Bernardi M; d'Amore ES; Zanon C; Madeo D; Rodeghiero F; Astori G
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):159-65. PubMed ID: 22818859
[TBL] [Abstract][Full Text] [Related]
9. Cord blood CD4
Liu A; Wang Q; Yang X; Shen S; Xu Y
Front Biosci (Landmark Ed); 2019 Jun; 24(7):1259-1270. PubMed ID: 31136978
[TBL] [Abstract][Full Text] [Related]
10. Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation.
Michelo CM; Fasse E; van Cranenbroek B; Linda K; van der Meer A; Abdelrazik H; Joosten I
Transpl Immunol; 2016 Jul; 37():1-9. PubMed ID: 27142560
[TBL] [Abstract][Full Text] [Related]
11. Human interferon-alpha increases the cytotoxic effect of CD56(+) cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines.
Durrieu L; Gregoire-Gauthier J; Dieng MM; Fontaine F; le Deist F; Haddad E
Cytotherapy; 2012 Nov; 14(10):1245-57. PubMed ID: 22974386
[TBL] [Abstract][Full Text] [Related]
12. [Mesenchymal stem cells inhibit the expression of CD25 on phytohaemagglutinin-activated lymphocytes].
Liu YB; Qian HR; Hong DF; Wang JW; Li JT; Wang XA; Kun Y; Ma XM; Chen Y; Chen DQ; Weng WH; Peng SY
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2136-9. PubMed ID: 17988536
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem cells promote the sustained expression of CD69 on activated T lymphocytes: roles of canonical and non-canonical NF-κB signalling.
Saldanha-Araujo F; Haddad R; Farias KC; Souza Ade P; Palma PV; Araujo AG; Orellana MD; Voltarelli JC; Covas DT; Zago MA; Panepucci RA
J Cell Mol Med; 2012 Jun; 16(6):1232-44. PubMed ID: 21777379
[TBL] [Abstract][Full Text] [Related]
14. Higher frequency of regulatory T cells in granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts compared with G-CSF-primed peripheral blood grafts.
Zhao XY; Wang YT; Mo XD; Zhao XS; Wang YZ; Chang YJ; Huang XJ
J Transl Med; 2015 May; 13():145. PubMed ID: 25948100
[TBL] [Abstract][Full Text] [Related]
15. [Effects of MSC on cell cycle, phenotype and cytokine secretion of T cells activated by PHA].
Luan XY; Zhang GB; Hu YM; Yu GH; Wang MY; Duan QY; Duan X; Zhang XG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 May; 23(5):402-5. PubMed ID: 17488597
[TBL] [Abstract][Full Text] [Related]
16. [Effect of human bone marrow mesenchymal stem cells on allogeneic regulatory T cells and its possible mechanism].
Yang J; Wang QH; Zeng QT; Mao XB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):785-9. PubMed ID: 17708804
[TBL] [Abstract][Full Text] [Related]
17. Functional significance of the activation-associated receptors CD25 and CD69 on human NK-cells and NK-like T-cells.
Clausen J; Vergeiner B; Enk M; Petzer AL; Gastl G; Gunsilius E
Immunobiology; 2003; 207(2):85-93. PubMed ID: 12675266
[TBL] [Abstract][Full Text] [Related]
18. Significance of Frequencies, Compositions, and/or Antileukemic Activity of (DC-stimulated) Invariant NKT, NK and CIK Cells on the Outcome of Patients With AML, ALL and CLL.
Boeck CL; Amberger DC; Doraneh-Gard F; Sutanto W; Guenther T; Schmohl J; Schuster F; Salih H; Babor F; Borkhardt A; Schmetzer H
J Immunother; 2017; 40(6):224-248. PubMed ID: 28557814
[TBL] [Abstract][Full Text] [Related]
19. An increase in CD3+CD4+CD25+ regulatory T cells after administration of umbilical cord-derived mesenchymal stem cells during sepsis.
Chao YH; Wu HP; Wu KH; Tsai YG; Peng CT; Lin KC; Chao WR; Lee MS; Fu YC
PLoS One; 2014; 9(10):e110338. PubMed ID: 25337817
[TBL] [Abstract][Full Text] [Related]
20. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
